PDPP, a polyvalent-directed peptide polymer, recognized breast cancer stem cells using combinational peptides P6 and P7, displaying a higher affinity and inhibition potential against the CD44 biomarker in breast CSCs [154]. This evidence concerns the gene CD44 and breast carcinoma.